Per Lindnér
Impact in
- Ophthalmology top 2%
- Ocular Oncology and Treatments
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Hepatology 15
- Hepatocellular Carcinoma Treatment and Prognosis 15
-
- Renal Transplantation Outcomes and Treatments 10
- Co-authors
- Magnus Rizell (22 shared papers)Roger Olofsson Bagge (16 shared papers)Jan Mattsson (13 shared papers)Christian Cahlin (13 shared papers)Peter L. J. Naredi (21 shared papers)Michael Olausson (9 shared papers)Larsolof Hafström (3 shared papers)L Hafström (7 shared papers)
In The Last Decade
Per Lindnér
69 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 72
- Ophthalmology 332
- Hepatology 252
- Transplantation 78
- Oncology 455
- Surgery 200
Countries citing papers authored by Per Lindnér
This map shows the geographic impact of Per Lindnér's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per Lindnér with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per Lindnér more than expected).
Fields of papers citing papers by Per Lindnér
This network shows the impact of papers produced by Per Lindnér. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per Lindnér. The network helps show where Per Lindnér may publish in the future.
Co-authors
The 25 scholars most cited alongside Per Lindnér, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 120 | |
| 2 | 2002 | 119 | |
| 3 | 2020 | 119 | |
| 4 | 2014 | 95 | |
| 5 | 1994 | 68 | |
| 6 | 1994 | 49 | |
| 7 | 2023 | 46 | |
| 8 | 2013 | 45 | |
| 9 | 2013 | 42 | |
| 10 | 1999 | 39 | |
| 11 | 2004 | 34 | |
| 12 | 2008 | 34 | |
| 13 | 2015 | 34 | |
| 14 | 2015 | 32 | |
| 15 | 2014 | 30 | |
| 16 | 2003 | 29 | |
| 17 | 2021 | 29 | |
| 18 | 2020 | 28 | |
| 19 | 2020 | 26 | |
| 20 | 1994 | 25 |
About Per Lindnér
Per Lindnér is a scholar working on Hepatology, Transplantation, Oncology, Ophthalmology and Immunology, having authored 70 papers that have together received 1.5k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (15 papers), Cutaneous Melanoma Detection and Management (10 papers), Ocular Oncology and Treatments (10 papers), Renal Transplantation Outcomes and Treatments (10 papers), Colorectal Cancer Treatments and Studies (7 papers), Organ Transplantation Techniques and Outcomes (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Intraperitoneal and Appendiceal Malignancies (4 papers). The work is most often cited by research in Ophthalmology (332 citations), Hepatology (252 citations), Transplantation (78 citations), Oncology (455 citations) and Surgery (200 citations). Per Lindnér has collaborated with scholars based in Sweden, Denmark and Australia. Frequent co-authors include Magnus Rizell, Roger Olofsson Bagge, Jan Mattsson, Christian Cahlin, Peter L. J. Naredi, Michael Olausson, Larsolof Hafström, L Hafström, Mats Andersson and Lars Ny. Their work appears in journals such as Annals of Surgical Oncology, European Journal of Surgical Oncology, Trials, Acta Oncologica and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.